Busca
Exibindo 1591 - 1620 de 2726
In 2020, research operations did not take place in Antarctica due to the restrictions enforced by the COVID-19 pandemic. At the same time, the current public health crisis has shown the importance of knowledge in health, of surveillance, and of an integration of human, environmental, and animal health, in order to respond to present and future challenges. For this reason, teams are preparing for new research missions this year and are already debating ways to provide even more robust responses to the Unified Health System (SUS) and to society. The upcoming missions of the FioAntar project (…
Article
A recently published study, with the participation of the Oswaldo Cruz Foundation - Fiocruz, suggests that the Delta variant of the new coronavirus, first detected in India, may increase the risk of reinfection. The research shows that the serum of people previously infected by other strains is less powerful against this viral variant. The problem is markedly observed among individuals previously infected by the Gamma variant, originally identified in Manaus, Brazil, and currently the dominant strain in the country, as well as by the Beta variant, first detected in South Africa. In these…
Article
The notion that health crises unfairly and disproportionately affect vulnerable populations was observed and documented during the greatest health crisis of this century. Furthermore, studies have shown that the distribution of COVID-19 is unequal among different ethnic and socioeconomic groups (Horta, 2020 and Wang, 2020) iii. They also highlight the importance of prejudice and systemic racism as elements that, when intertwined with biological characteristics, behaviors, and environmental factors, lead people to a situation of inequitable social…
Article
Over the past week, the four central units of large processing of molecular tests (RT-PCR) for Covid-19 coordinated by the Ministry of Health, with the support of Fiocruz, achieved the equivalent of 7 million samples processed, which represents about 40% of all testing done in the public system. In addition to processing the tests, Fiocruz is also responsible for their production, having already concluded its committment, signed in 2020 with the Ministry of Health (MS), of delivering 11.7 million molecular tests for Sars-CoV-2. The tests are still being delivered according to the Ministry’s…
Article
Cooperation between the so-called Global South countries took a hard hit during the COVID-19 pandemic, suffering backtracks due to political and ideological issues in the past few years, but it has the potential to help these nations overcome the public health crisis with a sustainable recovery. These were some of the reflections raised during the South-South Cooperation seminar, diplomacy in health and pandemic that the Fiocruz Global Heath Center (Cris/Fiocruz) held last Wednesday (June 23rd).
Mediated by Regina Ungerer, physician, and researcher of Cris/Fiocruz, the webinar…
Article
A study developed in partnership between Fiocruz Pernambuco, the Federal Rural University of Pernambuco (UFRPE) and the Federal Institute of Paraíba (IFPB) carried out an investigation on the evolution over time of the daily numbers of deaths by COVID-19, taking into account the scenario in 43 countries. Using physical approaches and information theory techniques, the researchers achieved results that give scientific evidence as for the efficiency of measures such as the use of face masks, social distancing, quarantines, mass testing, and education on hygiene, to restrict the impacts of the…
Article
Fiocruz was elected a member of the Joint Coordinating Board of the WHO’s Special Program for Research and Training in Tropical Diseases (TDR). The election took place last Thursday (June 17), during the Council’s 44th meeting, giving the Foundation a mandate spanning from January 1st, 2022, to December 31st, 2025.
“This acknowledgment of Fiocruz is a momentous event. Together with the Council, the Foundation will seek to go deeper into proposals bound to a vision that takes into account mainly neglected populations all over the world, by means of efforts in the field of research, education…
Article
Last Sunday (June 20), the Municipality of Rio de Janeiro vaccinated the entire eligible population of the island of Paquetá (those above 18 years of age), including pregnant women, against Covid-19. The PaqueTá Vacinada project (Paquetá Is Vaccinated, in loose translation) by the Municipal Health Secretary (SMS) aims to evaluate the effects of large-scale vaccination on the island’s population and was approved by the Ethics Committees in Research of the municipal government and of the Ministry of Health (MS). Kick-started in the morning, the event was attended by the Ministry of Health,…
Article
Following the agreement between Fiocruz and The Global Health Network, the course Speech therapy healthcare: oral sensory-motor disorders in the field of neonatology is now available at the Global Health Training Centre in three languages: English, Spanish and Portuguese. The course was developed by a multiprofessional team from the National Institute of Women, Children and Adolescents Health Fernandes Figueira (IFF/Fiocruz) and aimed at speech therapists and other health workers interested in the topic of dysphagia (difficulty in swallowing).
The course Coordinator, Mariangela Bartha, has a…
Article
A study by Public Health England (PHE) showed that applying two doses of the AstraZeneca vaccine results in 92% effectiveness against hospitalization due to the Delta (B.1.617.2) variant of the Sars-CoV-2. The variant, formerly known as the Indian variant, has been spreading through the United Kingdom like wildfire and there have been confirmed cases in Brazil as well. The vaccine has also shown high effectiveness against the Alpha (B.1.1.7) variant, first identified in the UK, with a reduction of 86% in hospitalizations.
The study by the British government health agency, published as pre-…
Article
Led by Australia, a new trial will investigate whether it is possible to predict who remains susceptible to the variants of Sars-CoV-2, even when they received a vaccine against COVID-19 or have already been sick due to the virus. The research will be exploring the immune response of vaccines specific against the disease in Brazilian health workers, in order to identify biomarkers that can indicate whether someone will be protected (or remains at risk of contracting COVID-19), if exposed to a variant of Sars-CoV-2.
The study received philanthropic financing from the Bill & Melinda Gates…
Article
The G7 summit wraps up an important cycle of top-level meetings to evaluate and propose directions for the global fight against the COVID-19 pandemic. Preceded by the G20 Summit on Global Health and the World Health Assembly, both held during the second half of May, the G7 Summit took place last week in Carbsi Bay, Cornwell, United Kingdom, the first to be held after the Trump era.
One of the priority topics was the pandemic. The world had high expectations for the summit, attended by chiefs of State and of government of seven of the world’s largest economies, holders of about 60% of the…
Article
Published in The New England Journal of Medicine, the results of a randomized controlled trial (RCT) showed a reduction of 77% of cases of dengue fever in areas that received the Aedes aegypti mosquito with Wolbachia, in Yogyakarta, Indonesia. This is the same technique employed in Brazil (the Wolbachia method), an initiative led by Fiocruz in the country.
The study also reveals an 86% reduction in hospitalizations in areas treated with Wolbachia, proof that the effectiveness of the method is equivalent for all four serotypes of dengue fever. “These results show how Wolbachia can be a…
Article
The Vice-Presidency of Research and Biological Collections (VPPCB) makes available a paper with recommendations to regulate the Nagoya Protocol in Brazil.
On June 2, 2021, Brazil became a party to the Nagoya Protocol, after depositing its letter of ratification at the United Nations (UN) Secretariat on March 4, 2021.By joining the Nagoya Protocol, Brazil took a very relevant step to be inserted in the global context of access to genetic resources and associated traditional knowledge and benefit sharing, however it is necessary to adjust its domestic legislation (Law 13,123 / 2015…
Article
Still in the heat of the World Health Assembly and the G20 Global Health Summit, held at the end of May, the Advanced Seminar of the Fiocruz's Global Health Center (CRIS/Fiocruz) brought, last Wednesday (6/10), the main conclusions and challenges for this biennium, in a challenging conjuncture during the COVID-19 pandemic. To account for such a broad issue, the webinar Global Health Agenda 2021 brought together eight debaters and was held in two parts: one in the morning and one in the afternoon, in what Paulo Buss, coordinator of CRIS/Fiocruz, defined as "a double journey".
The 74th Assembly…
Article
"Data and information will be fundamental to understand the dynamics of health inequality reduction processes and establish better public policies and institutional arrangements to respond to and prevent upcoming crises, while contributing to the Unified Health System [SUS, acronym in Portuguese for the Brazilian public health system] improvement", said Nísia Trindade this Monday (September 7), during the event organized by The Trinity Challenge with the theme Opportunities in information science and data analysis in public health. Besides the president of Fiocruz, the event also counted…
Article
The Bulletin of the Fiocruz COVID-19 Observatory, released last Friday (June 4th), concluded there is a rising trend for Severe Acute Respiratory Syndrome (SARS) in 12 states, in addition to the Federal District, in epidemiological week 21, between May 23rd and 29th. All regions have worrying figures, mainly those in the South and in the Central-West Brazilian regions. About 96% of SARS cases are caused by the new coronavirus.
The relation between COVID-19 and maternal deaths is another highlight of this release. Pregnant women and women who have recently given birth are increasingly becoming…
Article
The Independent Panel on Pandemic Preparedness1 released on 11 May adds to the mounting calls for a new Pandemic Treaty that would address gaps in the global governance of threats to global health security. The emerging debate has quickly turned to focus on questions of structure and forms — a United Nations treaty or a framework convention under the auspices of the WHO, and verification and enforcement mechanisms — as well as on issues of process regarding who will have voice and how the negotiations will proceed.2 3 But we must not lose sight of its purpose and key objectives, and what…
Article
International education webinar brings a circle of conversations with Brazilian researchers and their experiences in Germany and a German researcher experiencing our research institutions.
In a new edition of the PrInt Fiocruz-Capes International Seminar, the Brazil-Germany International Education Initiative organizes an online event to be held on June 8, 2021 at 10:00 am.
Seeking to stimulate the interest in scientific and cultural background associated with Education and Research in Germany, in this event we will have a round table with researchers from Brazil and Germany sharing their…
Article
Fiocruz and its Immunobiological Technology Institute (Biomanguinhos/Fiocruz) signed, on Tuesday (6/1), the contract for Technology Transfer of the COVID-19 vaccine (recombinant) with AstraZeneca for the 100% national production of the immunizing agent. The contract formalizes the transfer of knowledge that has already been passed on by the technological partner to speed up the production of the Active Pharmaceutical Ingredient (API) at the Biomanguinhos/Fiocruz facilities.
With the information received by then, the Institute carried out, in a few months, with funds from private donations,…
Article
Three projects, seven minutes of exhibition for each plus a private room to discuss them, exchange knowledge and pursue partnerships. The first edition of Translation Together Connect Series, last Friday (May 28), was a sort of pilot program for the webinars that are expected to become monthly, in an attempt to bring together members of this global alliance and boost projects in the field of translational science. Three Fiocruz researchers, Nicolas Carels, Lysangela Alves and William Provance, had the chance to present their research projects.
The webinar is a spin-off of Translation Together…
Article
This Wednesday (26/5), at a Deliberative Session at the Plenary, the Chamber of Deputies approved Bill 2077/2019 that establishes the title of Public Health National Heritage and awards it to Fiocruz. The title is granted to governmental and private non-profit institutions who provide relevant and remarkable services to public health and that have technical, scientific, educational, wellfare activities, activities of social participation, promotion, protection and recuperation of health. The institutions in question must have at least 70 years of activity, in addition to public and…
Article
The past few years have been frustrating for the international climate change agenda. The United Nations Convention on Climate Change (COP25) took place in 2019 in Madrid, but it was far from peaceful, after its cancellation in Brazil and in Chile. Many issues were left to be solved the following year, but in 2020, for the first time, the Convention did not happen, because of the pandemic. There is much catching up to be done and high expectations for COP26, which will take place in Glasgow, Scotland, in November this year. This was the evaluation done by ambassador Rubens Ricupero during the…
Article
In a paper published (5/25) on Nature Medicine, researchers of the Fiocruz Genomic Network and of partner institutions point to the cause of the increase in the number of COVID-19 cases in the state of Amazonas and of the successive replacements of lineages of Sars-CoV-2. The study shows that these factors have been boosted by a combination of reduced social distancing measures and the appearance of a new, more transmissible form of the virus, the P.1 variation, identified in mid-November 2020. This variant has caused an exponential increase in case numbers, thus establishing a second wave of…
Article
The rapid spread of some Sars-CoV-2 variants has been associated with reports of COVID-19 reinfection, based, for example, on the P.1 high prevalence in the first two months after its emergence. Given this scenario, researchers from Fiocruz Pernambuco and Foundation's Genomics Network members sought to verify what the real mechanisms behind reinfection might be. The initial hypothesis was that a greater competence of the new variants would bind to human host cells, but the result pointed in a different direction. According to the study coordinator and Fiocruz Pernambuco researcher, Roberto…
Article